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Abstract
Two extrinsic fluorescent probes, 3-(dimethylamino)-8,9,10,11-tetrahydro-7H-
cyclohepta[a]naphthalen-7-one (1) and 7-(dimethylamino)-2,3-dihydrophenanthren-4(1H)-one (2), 
are used to probe the unfolding of human serum albumin by sodium dodecyl sulfate (SDS). These 
probes respond separately to the polarity and H-bond donating ability of their surroundings. 
Competitive binding experiments show that flurophore 1 binds to site I (domain IIA) and 2 binds 
to site II (domain IIIA). The local acidity of 1 in site I is out of the sensing range of 1, whereas the 
local acidity of 2 in site II is calculated to be nearly zero on Catalan’s solvent acidity index. Both 
probes show that the first two equivalents of bound SDS result in a decrease in the local polarity of 
the binding sites. Each subsequent equivalent of SDS gives rise to a dramatic increase in polarity 
until HSA is saturated with seven molecules of SDS at the end of the specific binding domain. 
Compound 2 experiences an increase of acidity of 0.10 on Catalan’s solvent acidity index through 
seven equivalents of SDS, but the local acidity for 1 is still out of range. The increase in acidity 
experienced by 2 is greater than the increase in polarity. This result is consistent with greater 
exposure of the carbonyl group in 2, but not the bulk of 2, to the aqueous solvent in site II of the 
SDS-saturated HSA complex.
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Introduction
Human serum albumin (HSA) is the major protein in blood plasma that is responsible for 
transportation of hydrophobic molecules throughout the body.1 HSA contains just over 580 
amino acids, only one of which is tryptophan and seventeen of which are tyrosines. It has 
three α-helical domains designated I, II and III. Each of these domains is further divided 
into subdomains A and B. Small drug molecules are bound primarily at one of two sites 
(sites I and II as described by Sudlow) that are located in the A subdomains of II and III.2,3
HSA shows high affinity for long alkyl chain anions such as fatty acids and sodium dodecyl 
sulfate (SDS).4 Models suggest that these anions bind at the same sites.5 Crystal structures 
of HSA-fatty acid complexes reveal that there are seven primary fatty acid binding sites of 
various topologies.6,7 Three of these are high affinity sites. Binding at one of these three 
sites in particular leads to significant conformation changes in the protein. Fatty acid binding 
can also affect drug binding at sites I and II.
The intrinsic fluorescence of the single tryptophan (Trp 214) and of extrinsic dyes has been 
used to report on the physiochemical characteristics of the binding sites and in monitoring 
HSA unfolding.8,9 Following the fluorescence of Trp 214 with added SDS5,10 reveals four 
sequential stages or domains during unfolding.11 In order these stages are for specific 
binding, non-cooperative binding, cooperative binding and saturation binding. These 
domains have been documented using a variety of extrinsic fluorophores with bovine serum 
albumin (BSA), which is structurally similar to HSA.12–17 The initial interactions of HSA 
and BSA with SDS provide some stabilization and protection of the protein.17,18
The polarities of the binding sites in the serum albumins have been studied using a variety of 
fluorescent probes. Most common are molecules that possess an intramolecular charge-
transfer excited state (ICT) where the position of the fluorescence emission is affected by the 
local polarity.12–14,16,19–24 Other probes use excited-state intramolecular proton 
transfer15,17,25,26 and (ground-state) proton transfer27,28 to elucidate the binding site 
polarity.29
PRODAN (6-propionyl-2-dimethyaminonaphthalene, Figure 1) was prepared by Weber and 
Farris as an extrinsic fluorescent probe of BSA.30 PRODAN possesses an ICT excited state, 
and it has found considerable use as a polarity sensor, especially for lipid bilayers.31–35 Drug 
displacement studies and fluorescent resonance energy transfer studies show that PRODAN 
binds to site I of HSA.36,37 The emission maximum for HSA-bound PRODAN is at 22470 
cm−1, an increase of 3400 cm−1 from its maximum in water. The addition of palmitic acid to 
the HSA-PRODAN complex initially leads to an increase in fluorescence intensity. At higher 
concentrations palmitic acid displaces PRODAN from HSA.
While PRODAN is an often-used polarity sensor, its Stokes shift is also affected by specific 
H-bonding interactions.38–40 In fact, when its solvatochromic shifts are correlated using 
Catalán’s solvent parameters, the coefficient for the polarity term (SPP) is only double that 
of the solvent acidity (SA) term.41,42 The dependence of the emission maximum on both 
polarity and H-bonding complicates conclusions about its immediate environment.32,42
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Recently we have shown that emission intensities of 1 and 2 (Figure 1) are strongly 
quenched by H-bonding interactions.43,44 The correlation between the degree of quenching 
in an alcohol solvent, defined as log(Imax/I), and Catalán’s solvent acidity parameter 
SA41,45,46 is very linear. As such, the fluorescence intensity of these compounds can be used 
as sensors of H-bonding ability.47,48 PRODAN derivative 1 senses H-bonding in the upper 
end of the SA scale, whereas PRODAN regioisomer 2 is sensitive to low solvent acidities. 
The dual-sensing ability of 1 was used recently to characterize the local acidity of its 
cyclodextrin complex.49 In this paper we show that compounds 1 and 2 can be used to shed 
greater insight into the properties of the HSA binding sites, and, more importantly, changes 
in the properties of these sites through the specific binding stage of SDS-induced unfolding.
Experimental
Compounds 1 and 2 were prepared previously and sublimed under vacuum before 
use.43,50,51 Essentially fatty acid free HSA was purchased from Sigma-Aldrich. All solvents 
used in the solvatochromism studies were spectrophotometric grade except for 2-butanol, 2-
hexanol and 2-octanol, which were distilled from Na0 under N2 or vacuum. All HSA 
solutions were made in a 0.05 M phosphate buffer at pH 7.4 in polished water. Fluorescence 
emission data were collected using a fiber optic system with a 366 nm or 405 nm LED light 
source and an Ocean Optics Maya CCD detector. Absorption spectra were obtained from the 
same fiber optic system with a miniature deuterium/tungsten light source. Relative molar 
absorptivities were determined by the method of standard additions.48 Binding isotherm data 
were generated from the emission spectra of a series of aqueous solutions at 23°C in which 
the fluorophore concentration was held constant and the HSA concentration was varied. The 
following procedure was typical: 10–20 μL of a stock solution of fluorophore (ca. 5 mg/10 
mL ROH) and a variable volume (0 to 5000 μL) of a stock solution of HSA (ca. 180–360 
mg/ 50 mL buffer) were diluted to 5 mL with buffer. Reference solutions of the same 
concentration of fluorophore in the various alkanols were also prepared. Raw fluorescence 
intensities were adjusted to account for the detector spectral response and for the conversion 
from wavelength to wavenumbers.48,52 Plots of the integrated intensity ( ) dṽ) vs. 
[HSA] were fit to equation 1 using non-linear least squares. The limiting intensity of the 
plot, IL,is the intensity of the fluorophore-HSA complex, while  is the emission factor 
ratio between the fluorophore solvated in water and complexed with HSA. This factor 
accounts for differences in the absorption at the excitation wavelength and in the relative 
quantum yields (equation 2). The emission center-of-mass was calculated as ṽCM = ∫I(ṽ)•ṽ 
dṽ/∫I(ṽ) dṽ.
(1)
(2)
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For the solvent acidity calibrations the integrated emission intensities of 1 and 2 in several 
reference solvents are converted to emission factor ratios fref by correcting for the different 
indices of refraction (equation 3).
(3)
Rearranging equation 3 gives the ratios of the relative quantum yields of the complex vs. 
reference solvent (equation 4).
(4)
The apparent solvent acidities (SAapp) in the complexes are determined through equation 5. 
The slope m is determined from the plot of −log(Φref) vs. SA.
(5)
Results and Discussion
Compounds 1 and 2 are very hydrophobic and form strong complexes with HSA. Under 
conditions where HSA is in great excess, the binding constant for the highest affinity 
binding site can be determined from the binding isotherm using equation 1. Both 1 and 2 are 
strongly quenched in water, so the emission factor ratios  are very small and, in fact, 
nearly zero with 2. Figure 2 shows that HSA binds 1 more strongly than 2. The binding 
constants are 1.48±0.07 × 105 and 5.3±0.4 × 104 M−1, respectively. These values are smaller 
than the binding constant of PRODAN with HSA reported by González-Jiménez (4.2 × 105 
M−1), but they bracket the value reported by Panda (9.2 × 104 M−1).36,37 Weber and Farris 
determined the binding constant of PRODAN with BSA to be 105 M−1.30
The binding sites on HSA for 1 and 2 are established through competitive binding studies. 
The competitive binders for site I and site II are warfarin for site I (K = 3.4 × 105 M−1) and 
S-naproxen for site II (K = 3.7 × 106 M−1).53 Both of these drugs have higher affinity 
towards HSA than does either 1 or 2. Figure 3 shows that both compounds are displaced by 
one drug but not the other. For compound 1 the addition of warfarin causes a significant 
decrease in the intensity without altering ṽCM. On the other hand, naproxen induces only a 
small but variable change in the intensity, but a decrease of over 200 cm−1 in ṽCM. For 2 the 
addition of naproxen causes an even greater decrease in intensity compared to the effect of 
added warfarin on 1-HSA, while the addition warfarin actually leads to an increase in 
fluorescence. These results suggest that 1 binds to site I, whereas 2 binds to site II. 
PRODAN is reported to bind to site I.36 PROMEN (6-propionyl-2-methoxynaphthalene), 
while structurally very similar to PRODAN, is reported to bind to Site II.29,54 Results from 
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molecular docking studies (Supplementary Information) show that both 1 and 2 are bound in 
Sites I and II. The preferences for one binding site over the other in either case are very 
small.
Compounds 1 and 2 sense both micropolarity and microacidity. The effective polarity 
surrounding the fluorophores in the 1-HSA and 2-HSA complexes are related to the ṽCM 
values, whereas the effective solvent acidities are related to the fluorescence intensities. The 
Dimroth-Reichart ET(30) values are the mostly widely used measures of polarity.55 The ṽCM 
values for 1 and 2 show reasonable linear correlations with this parameter over a range of 
apolar, aprotic, polar and protic solvents (Figure 4). The fluorescence center-of-mass for 1-
HSA is 21550 cm−1 corresponding to an ET(30) value of 42.1. This polarity is roughly the 
same as acetone, but smaller than that of isopropanol (48.4) where ṽCM is 19950 cm−1. For 
2-HSA the ṽCM value is 18790 cm−1 corresponding to an ET(30) value of 38.4, a polarity 
similar to that of ethyl acetate. The polarity surrounding 2 in site II is significantly smaller 
than the polarity of 1 in site I.
The micropolarities of these fluorophores in their HSA complexes are low in comparison to 
polarities determined for other fluorophore-HSA complexes. Norharmane and an 
indoloquinolizine derivative show ET(30) values of 54.9 and 50.3, respectively.20,27,28 The 
micropolarities of BSA-fluorophore complexes have received more attention. Most of these 
are ICT probes, and ET(30) values of 39.0,13 39.5,14 40.6,23 44.2,56 46.0,16 46.757 and 
48.412 have been determined. On the other hand, the 3-hydroxychromone derivative of 
Demchenko, Klymchenko and Ercelen that binds to site I of HSA shows an ET(30) value of 
37.8 (ETN = 0.22).58,59
The microacidity-sensing abilities of these compounds are based on the strong quenching 
that they suffer in protic solvents as a result of H-bonding interactions.47,48 The acidity 
determinations are made by comparing the fluorescence intensities of the complexes and 
with the intensities of the fluorophores in several reference solvents. The fluorescence 
intensities of the complexes are given by the limiting intensities from the binding isotherms 
(IL in eqn 1). The intensities are converted to relative quantum yields by adjusting for the 
differing molar absorptivities at the excitation wavelengths and the differing indices of 
refraction. Compound 1 is sensitive to solvent acidity in the range of isopropanol 
(SA=0.283) to water (SA=1.062), whereas compound 2 responds to acidities less than that 
of ethanol (SA=0.4). For 1-HSA the relative quantum yield is nearly as great as that of 1 in 
isopropanol (data not shown) in which there is little quenching. Because the ṽCM value for 
the 1-HSA complex indicates an effective polarity that is much less than that of isopropanol, 
it is likely that the effective solvent acidity is also less than that of isopropanol (0.28). That 
is, the acidity of 1-HSA is below the range that 1 is able to sense.
The calibration curve for the solvent acidity determination of the 2-HSA complex is shown 
in Figure 5. Previously, the range of solvent acidities was determined only with a lower 
bound of 0.145 (t-butanol).48 For the current study, the range is extended with references at 
0.14 (2-hexanol), 0.88 (2-octanol) and 0.0 (toluene). The y-intercept of the best fit line of the 
plot of log(Φ2-HSA/ΦROH) vs. the solvent acidity parameter determines the effective acidity 
of the 2-HSA complex. The intercept is nearly at the toluene reference point, and the 
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effective acidity is calculated to be 0.01. This number is extremely low, and it is likely that it 
is only a lower bound. Without H-bonding interactions to deactivate the fluorescence of 2, 
the influence of other factors, like the reduced collisional coupling with its surroundings and 
incomplete dipolar relaxation, will lead to greater fluorescence than in isotropic solution.60 
Greater fluorescence intensity will translate as a lower effective solvent acidity. On the other 
hand, the ṽCM value for the complex (18790 cm−1) is much closer to the ṽCM value for 2 in 
toluene (19680 cm−1) than for 2 in 2-octanol (17310 cm−1), suggesting that a low effective 
SA assignment is warranted. These results suggest that 1 and 2 have very little exposure to 
the surrounding water.
These two sensors shed light on the beginning of the denaturation process with the detergent 
SDS in the specific binding range. In this binding domain each molecule of SDS binds 
successively to HSA until the HSA host is saturated. After that, the SDS molecules bind in a 
non-cooperative manner. The saturation limit occurs with ~seven molecules of SDS. Figure 
6 shows the titration of the HSA complexes with SDS. The mole ratio of the SDS with HSA 
(based on concentrations) is used as the abscissa, and HSA is used in 100% excess of either 
fluorophore. The effect of SDS on the fluorescence intensity of the 1-HSA complex (Figure 
6A) is what is often observed with other fluorophores; that is, addition of SDS causes an 
increase in the fluorescence. The maximum intensity is reached at the end of the specific 
binding domain. While the fluorescence intensity is increasing, the fluorescence center-of-
mass exhibits sigmoidal behavior. It increases slightly through two equivalents of SDS, then 
it sharply declines until the titration reaches seven equivalents of SDS. The change in the 
ṽCM value amounts to 690 cm−1, and ṽCM shifts to 20450 cm−1. Part of the increase in 
fluorescence intensity is due to stronger binding. With six equivalents of SDS the binding 
constant increases to 5.0 × 105 M−1 (Figure 2). The ṽCM values in the binding isotherm in 
Figure 2 show that the ratio of bound SDS to HSA does not drop even at low HSA 
concentrations. If they did, the ṽCM values would increase according to the behavior seen in 
Figure 6. Instead, they decrease due to the contribution of free 1 in solution. The remainder 
of the increase in fluorescence is due to an increase in the quantum yield in the 1-HSA-SDSn 
complex. The fluorescence quantum yield of compound 1 is known to increase with 
increasing solvent polarity due to optimal formation of the intramolecular charge transfer 
state. By comparison the ṽCM value for 1 in isopropanol is 20200 cm−1. Thus, 1 experiences 
a significant increase in polarity through the specific binding region of denaturation. 
Because the ṽCM is still greater than that in isopropanol, the effective acidity surrounding 1 
may still be too low to be sensed by 1. Thus, it is not clear whether the increase in polarity is 
associated with an increase in solvent exposure.
Even though 2 binds at a different site than 1, it also experiences a significant increase in 
polarity (ΔṽCM = 820 cm−1) through the specific binding domain (Figure 6B). In contrast to 
1, the fluorescence intensity decreases precipitously after an initial increase. The decrease in 
intensity is associated with a decrease in ṽCM, and hence an increase in polarity. The drop in 
fluorescence intensity is not due to dislodgement by SDS. As with 1, the binding of 2 by 
HSA increases three-fold with SDS complexation (from 5.0 × 105 M−1 to 1.5 × 106 M−1, 
Figure 2). Again, because ṽCM does not vary during the titration, the stoichiometry of the 
HSA-SDSn complex must remain nearly constant. In this case, the drop in fluorescence 
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intensity can be ascribed to deactivation by H-bonding. When the SDS titration is done in 
D2O buffer, the decrease in intensity is significantly less (Figure 6B). Through fourteen 
equivalents of added SDS 2 experiences a 77% decrease in fluorescence intensity in H2O vs. 
only a 41% drop in D2O. While the change in intensity is less in D2O than in water, the ṽCM 
values show similar sigmoidal behavior. The diminution in quenching in D2O is consistent 
with H-bonding being responsible for the increased quenching.
While the D2O results are definitive for establishing the mode of deactivation for 2 in the 
HSA-SDSn complex, there is still the possibility that SDS induces a dislocation of the 
fluorophore from one binding site to another,61 one where the second site is more solvent 
accessible. This possibility can be addressed by titrating ternary complexes, one with a 
competitive binder in the free primary drug site and the other with a competitive binder that 
displaces 1 or 2 from their preferred site. Figure 7 shows the SDS titration of 1-HSA with 
warfarin and naproxen. The initial ṽCM for the ternary complexes are ~600 cm−1 lower than 
for the binary complexes. Warfarin should dislocate 1 from site I. While the decrease in ṽCM 
is similar to that without warfarin, its onset is sooner, and it is accompanied by an early 
onset of the maximum fluorescence intensity at ~two SDS equivalents. Naproxen should 
block site II from any dislocation of 1 from site I. Just as is seen in Figure 6 without 
naproxen, ṽCM decreases after an initial increase, and it reaches the same minimum at 
~20600 cm−1. The increase in fluorescence intensity shows as similar maximum position at 
~five SDS equivalents. While these results are mixed, they suggest that 1 does not dislocate 
from site I to site II during titration with SDS.
The results are more definitive with the SDS titrations of the 2-HSA-drug ternary 
complexes. Figure 8A shows that the 2-HSA-warfarin complex behaves just like the 2-HSA 
complex. Both the intensity and ṽCM reach a maximum at two equivalents of SDS, then 
decrease quickly. While the 2-HSA-naproxen complex shows similar behavior in the 
fluorescence intensity, the ṽCM does not show the same initial increase through two 
equivalents of SDS. These results suggest that 2 does not dislocate from site II to site I 
during the SDS titration.
From the calibration curve in Figure 5 the increase in quenching for the 2-HSA-SDSn 
complex can be correlated with an increase in SA of 0.10. This value corresponds to a 
solvent that has stronger H-bond donation than 2-octanol. On the other hand, the ṽCM value 
for the complex is 18200 cm−1, but the ṽCM for 2 in 2-octanol is only 17300 cm−1. The 
increase in H-bond quenching is greater than the increase in polarity as measured by the 
ṽCM value. This disparity suggests that the 2-HSA-SDSn complex undergoes significant 
changes as the number of bound SDS molecules increases. These changes are either in the 
protein conformation itself or possibly in the orientation of 2 in the binding pocket. Unlike 
site I which faces subdomain IIIA, the opening to site II is known to be exposed to the 
solvent.62 Either way, the result is much greater exposure of the carbonyl oxygen to the 
solvent, while the rest of the fluorophore remains fairly protected in a hydrophobic pocket. 
The increase in effective polarity can be explained in part, if not entirely, by the greater 
exposure to solvent.
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In conclusion, dual fluorescent sensors 1 and 2 reveal facets of the initial phase of 
denaturation of human serum albumin through the specific binding region. Both sensors 
show that the respective binding sites become less polar with two equivalents of SDS. With 
additional equivalents the polarity of both sites increases dramatically until the beginning of 
the noncooperative binding region. Compound 1, being sensitive to H-bonding in 
environments with effective solvent acidity greater than that of isopropanol, is not able to 
discern whether the polarity increase is due to greater solvent exposure. For compound 2, the 
increase in effective polarity is due to solvent exposure as shown by the significant H-
bonding induced fluorescence quenching.
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Figure 1. 
Structures of PRODAN and derivatives 1 and 2.
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Figure 2. 
Binding isotherms of 1 (Δ, ) and 2 (◊, ) with HSA and binding isotherms of 1 (○, 
) and 2 (□, ) with HSA and six equivalents of SDS ([SDS]/[HSA] is held constant 
at ~ 6) along with the corresponding emission center-of-mass: 1 (+, ) and 2 (×, ).
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Figure 3. 
Competitive binding experiments of (A) 1-HSA with warfarin, (B) 1-HSA with naproxen, 
(C) 2-HSA with warfarin and (D) 2-HSA with naproxen. HSA is 25 μM and 1is 2 μM in (A) 
and (B). HSA is 25 μM and 2 is 6 μM in (C) and (D). Relative intensities are shown in black 
(◊, ), while the emission center-of-mass is shown in red (+, ).
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Figure 4. 
Plots of (A) ṽCM vs. ET(30) for 1 in cyclohexane, toluene, chlorobenzene, diethyl ether, 
chloroform, methylene chloride, ethyl acetate, acetone, dimethyl sulfoxide, acetonitrile, 
isopropanol and ethanol and (B) ṽCM vs. ET(30) for 2 in toluene, chlorobenzene, diethyl 
ether, chloroform, methylene chloride, ethyl acetate, acetone, dimethyl sulfoxide, sec-
butanol and isopropanol.
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Figure 5. 
Plot of the logarithm of the ratio of quantum yields between the 2-HSA complex(Φ2-HSA) 
and five reference compounds (toluene, 2-octanol, 2-hexanol, 2-butanol and isopropanol, 
Φref) vs. their solvent acidity parameters (SA).
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Figure 6. 
SDS titration curves: (A), 1-HSA, fluorescence intensity (◊, ) and ṽCM (+, ), HSA 
is 27 μM and 1 is 0.8 μM; (B), 2-HSA, fluorescence intensity in phosphate buffer (◊, ) 
and in D2O buffer (□, ) and ṽCM in phosphate buffer (+, ) and in D2O buffer (×, 
), HSA is 100 μM and 2 is 6 μM in phosphate buffer and 140 μM and 3 μM, 
respectively, in D2O buffer.
Green and Abelt Page 17
J Phys Chem B. Author manuscript; available in PMC 2017 September 13.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 7. 
SDS titration curves with competitive binders: (A), 1-HSA with warfarin, fluorescence 
intensity (◊, ) and ṽCM (+, ), HSA is 27 μM, 1 is 8 μM and warfarin is 86 μM; (B), 
1-HSA with naproxen, fluorescence intensity (◊, ) and and ṽCM (+, ), HSA is 26 
μM, 1 is 8 μM and naproxen is 82 μM.
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Figure 8. 
SDS titration curves with competitive binders: (A), 2-HSA with warfarin, fluorescence 
intensity (◊, ) and ṽCM (+, ) HSA is 26 μM, 2 is 12 μM and warfarin is 86 μM; 
right: 2-HSA with naproxen, fluorescence intensity (◊ ) and ṽCM (+, ), HSA is 25 
μM, 2 is 12 μM and naproxen is 48 μM.
Green and Abelt Page 19
J Phys Chem B. Author manuscript; available in PMC 2017 September 13.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
